-The Economic Times, The Cabinet has cleared a proposed Bill empowering the Reserve Bank of India (RBI) to regulate all microfinance institutions (MFIs). A central legislation makes sense only to the extent that it over-rides draconian state-level laws. However, the Bill suffers from many infirmities. And it is unfortunate that these have been overlooked. The law, if enacted, is likely to kill small MFIs and hurt the sector that is struggling...

Jatav residents of Ramgarh in U.P. resist attempts by members of a powerful community to grab their land by violent means. IN what could be considered one of the worst incidents of vendetta against Dalits in the National Capital Region (NCR), members of the Dalit Jatav community were beaten up brutally by some members of the dominant Gujjar community in Ramgarh village in the Greater Noida area of Uttar Pradesh...

Veteran agricultural scientist and alumnus of Harvard and Berkeley Universities, Dr Peter Kenmore was in Mumbai for NABARD’s 30th anniversary lecture on ‘Future of Global Agriculture: Challenges and Opportunities for India.’ This United Nations Food & Agriculture Organization India representative spoke to Yogesh Pawar on the current scenario in agriculture. Some excerpts: There’s a lot of churn over GM technology in India. At a time when the country is grappling with...

Pawar’s Report Card The Negatives     Per capita availability of cereals and pulses has fallen in last eight years     No improvement in irrigation, 60% of agriculture still dependent on monsoons     Farmers growing cereals, sugarcane, oilseeds and pulses assured higher MSP, but majority don't benefit     Production up, but not productivity. Farmer suicides are on the rise.     Poor market advisory on exports being misused to buy cheaply from farmers and make profits overseas     Pawar...

Fighting cancer has just become less expensive for millions of Indian patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...